A divided U.S. Supreme Court threw out a Los Angeles ordinance that lets police inspect hotel registries without first getting a judge’s permission. Similar laws are in place in Indianapolis, Atlanta, Detroit, Seattle, St. Louis and Cincinnati.
Driving the consolidation is the 2010 health law that put tougher rules on the industry, demanding more covered services, better care and a ceiling on profits.
Anthem on Saturday offered to buy the smaller health insurer, which responded Sunday with a litany of concerns and criticisms.
U.S. regulators have delivered a victory for engine makers such as Indiana-based Cummins Inc. in a battle over greenhouse-gas emissions regulations for heavy-duty trucks.
If true, the move could signal that Indianapolis-based Simon Property Group no longer is interested in acquiring the rival shopping-mall owner.
The price tag for a football from last season’s infamous AFC Championship game between the Colts and Patriots has been inflated.
The acquisition lets Hill-Rom, a maker of hospital supplies for wound care and respiratory health, delve further into the market for diagnostic supplies for physicians and emergency responders
The biggest U.S. providers—UnitedHealth Group Inc., Anthem Inc., Aetna Inc., Cigna Corp. and Humana Inc.—are all looking at possible combinations. Indianapolis-based Anthem is considering a takeover of Cigna or Humana, a person familiar with the matter said.
About 175 underperforming Gap stores will close in North America as part of a comeback plan for the business, which has posted sales declines for five straight quarters and lagged behind its sister chain Old Navy.
The purchase of Metro AG’s Galeria Kaufhof stores is Hudson’s Bay’s first under its joint venture with Simon Property Group, marking a new era of real-estate fueled growth as retailers try to squeeze more value from their property.
Intarcia Therapeutics Inc. is betting its matchstick-size pump could take market share from Eli Lilly and Co., AstraZeneca Plc and Novo Nordisk A/S.
Democrats handed President Barack Obama an embarrassing defeat on his trade agenda, blocking final passage of fast-track negotiating authority just hours after he made a rare visit to Capitol Hill to seek their support.
Axovant Sciences Ltd., a company without a finished product or a dime of sales, has an almost $3 billion valuation after its public-market debut. The IPO shows the staggering potential for any company that can develop a successful Alzheimer’s treatment.
The Obama administration is poised to deliver a victory to engine makers at the expense of truck manufacturers such as Cummins Inc. in the next stage of the U.S. government’s plan to tackle climate change.
Already considered one of the largest thefts of U.S. government personnel data in history, investigators now estimate that it may include data on as many as 14 million people, including every federal employee.
Subaru, which has thousands of workers in Indiana, has never seen so much demand from car buyers. But making big moves to boost output could hurt the very thing that customers love about the automaker—its smaller size.
Eli Lilly stock rose 5.4 percent per share on Tuesday, its biggest daily increase since March 2009, after Elanco President Jeffrey Simmons was asked if Lilly might one day shed the unit in an initial public offering.
Humana Inc. has pulled out of a major health care conference and said it will not comment on rumors of a merger, actions that will likely fuel Wall Street speculation that the insurer is part of a developing deal. Anthem Inc. is a possible suitor.
Indianapolis-based Eli Lilly and Co. plans to introduce its version of Sanofi’s Lantus insulin for diabetes in Europe in the third quarter, said Enrique Conterno, the president of Lilly Diabetes.
An experimental pill to treat low sexual desire in women moved closer to becoming the first such drug to be sold in the U.S. after regulatory advisers backed its approval.
